We are live on ! Find out more
FRA

Front Row Advisors Portfolio holdings

AUM $296M
1-Year Est. Return 34.73%
This Fund
S&P 500
This Quarter Est. Return
+3.24%
1 Year Est. Return
+34.73%
3 Year Est. Return
+122.22%
5 Year Est. Return
+164.22%
10 Year Est. Return
–
AUM
$137M
AUM Growth
+$8.91M
Cap. Flow
+$5.42M
Cap. Flow %
3.95%
Top 10 Hldgs %
25.75%
Holding
1,127
New
41
Increased
160
Reduced
183
Closed
74

Top Buys

Rank Stock Value
1
MDT icon
Medtronic
MDT
+$2.38M
2
BEAT
BioTelemetry, Inc.
BEAT
+$1.32M
3
RPM icon
RPM International
RPM
+$798K
4
DIS icon
Walt Disney
DIS
+$758K
5
COST icon
Costco
COST
+$641K

Top Sells

Rank Stock Value
1
IRBT
iRobot
IRBT
+$1.7M
2
MDSO
Medidata Solutions, Inc.
MDSO
+$958K
3
MSFT icon
Microsoft
MSFT
+$206K
4
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$129K
5
AAPL icon
Apple
AAPL
+$111K

Sector Composition

Rank Sector Weight
1 Technology 27.32%
2 Healthcare 15.28%
3 Financials 10.67%
4 Consumer Staples 7.75%
5 Consumer Discretionary 5.11%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SDY icon
351
State Street SPDR S&P Dividend ETF
SDY
$21.8B
$16K 0.01%
157
– –
TSM icon
352
TSMC
TSM
$2.11T
$16K 0.01%
396
-10
-2% -$412
VGK icon
353
Vanguard FTSE Europe ETF
VGK
$30.1B
$16K 0.01%
300
– –
WAB icon
354
Wabtec
WAB
$50.9B
$16K 0.01%
225
+56
+33% +$3.97K
XLI icon
355
State Street Industrial Select Sector SPDR ETF
XLI
$34B
$16K 0.01%
213
– –
ADP icon
356
Automatic Data Processing
ADP
$99.2B
$15K 0.01%
90
-4
-4% -$650
CF icon
357
CF Industries
CF
$19.1B
$15K 0.01%
314
– –
EW icon
358
Edwards Lifesciences
EW
$48.8B
$15K 0.01%
240
– –
FFIV icon
359
F5
FFIV
$22.1B
$15K 0.01%
102
– –
GATX icon
360
GATX Corp
GATX
$6.56B
$15K 0.01%
189
– –
MBB icon
361
iShares MBS ETF
MBB
$39.1B
$15K 0.01%
139
– –
MDYV icon
362
State Street SPDR S&P 400 Mid Cap Value ETF
MDYV
$2.77B
$15K 0.01%
300
– –
PGX icon
363
Invesco Preferred ETF
PGX
$3.84B
$15K 0.01%
1,000
– –
TTE icon
364
TotalEnergies
TTE
$191B
$15K 0.01%
273
-32
-10% -$1.75K
EON
365
DELISTED
E.ON AG ADS (REPTG 1/3 ORD SHS)
EON
$15K 0.01%
1,378
-36
-3% -$392
AES icon
366
AES
AES
$10.6B
$14K 0.01%
811
– –
BIIB icon
367
Biogen
BIIB
$29.9B
$14K 0.01%
58
+9
+18% +$2.08K
ET icon
368
Energy Transfer Partners
ET
$70.2B
$14K 0.01%
975
– –
HOG icon
369
Harley-Davidson
HOG
$2.75B
$14K 0.01%
380
– –
IBND icon
370
State Street SPDR Bloomberg International Corporate Bond ETF
IBND
$454M
$14K 0.01%
400
– –
IEMG icon
371
iShares Core MSCI Emerging Markets ETF
IEMG
$150B
$14K 0.01%
278
– –
MUR icon
372
Murphy Oil
MUR
$5.59B
$14K 0.01%
575
– –
SNY icon
373
Sanofi
SNY
$104B
$14K 0.01%
334
-64
-16% -$2.72K
WCN
374
Waste Connections
WCN
$42.5B
$14K 0.01%
150
– –
VE
375
DELISTED
VEOLIA ENVIRONNEMENT
VE
$14K 0.01%
588
+18
+3% +$429
13 14
15
16 17

Similar funds

SM
Skaana Management Brooklyn, New York $296M AUM 65.1% 1-Year Est. Return
RHP
Royal Harbor Partners Houston, Texas $295M AUM 14.06% 1-Year Est. Return
MSWM
Master's Wealth Management Lancaster, Pennsylvania $295M AUM 15.96% 1-Year Est. Return
RLIM
Red Lighthouse Investment Management New York $296M AUM 22.04% 1-Year Est. Return
JCM
Jacobsen Capital Management Salt Lake City, Utah $296M AUM 24.47% 1-Year Est. Return
CA
Claar Advisors New York $295M AUM 12.26% 1-Year Est. Return
NRC
New Republic Capital Charlotte, North Carolina $297M AUM 24.5% 1-Year Est. Return
MFC
Morris Financial Concepts Mount Pleasant, South Carolina $295M AUM 17.25% 1-Year Est. Return

Front Row Advisors's Q2 2019 Portfolio in Review

As of Q2 2019, Front Row Advisors held 1,127 positions worth $137M, up 6.9% from $128M the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Front Row Advisors deployed $5.42M of net new capital in Q2 2019, opening 41 new positions and adding to 160 existing holdings. Its largest new stake was BioTelemetry, Inc.: 25,089 shares worth $1.21M.

By sector, the portfolio is most concentrated in Technology at 27% of assets, down from 28% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Microsoft, an estimated $206K trimmed.

  • Front Row Advisors's largest Q2 2019 buy was BioTelemetry, Inc.: 25,089 shares worth $1.21M.
  • Front Row Advisors added most to Medtronic in Q2 2019, an estimated $2.38M increase.
  • Front Row Advisors's biggest Q2 2019 reduction was Microsoft, cutting an estimated $206K.
  • Front Row Advisors fully exited iRobot in Q2 2019, selling an estimated $1.7M.
  • Front Row Advisors's ten largest holdings make up 26% of its $137M portfolio in Q2 2019.
  • Front Row Advisors opened 41 new positions and closed 74 in Q2 2019.
  • Front Row Advisors's portfolio value rose 6.9% quarter-over-quarter to $137M.

Based on Front Row Advisors's 13F filing for Q2 2019, filed 27 Aug 2019.